Cargando…
The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome
Drug resistance is a known risk factor for poor tuberculosis (TB) treatment outcomes, but the contribution of other bacterial factors to poor outcomes in drug-susceptible TB is less well understood. Here, we generate a population-based dataset of drug-susceptible Mycobacterium tuberculosis (MTB) iso...
Autores principales: | Chen, Yiwang, Jiang, Qi, Peierdun, Mijiti, Takiff, Howard E, Gao, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188106/ https://www.ncbi.nlm.nih.gov/pubmed/37133242 http://dx.doi.org/10.7554/eLife.84815 |
Ejemplares similares
-
Whole-Genome Sequencing Exhibits Better Diagnostic Performance than Variable-Number Tandem Repeats for Identifying Mixed Infections of Mycobacterium tuberculosis
por: Chen, Yiwang, et al.
Publicado: (2023) -
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments
por: Liu, Qingyun, et al.
Publicado: (2020) -
High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study
por: Li, Meng, et al.
Publicado: (2022) -
Rapid adaptation of a complex trait during experimental evolution of Mycobacterium tuberculosis
por: Smith, Tracy M, et al.
Publicado: (2022) -
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity
por: Al Mahrouqi, Sara, et al.
Publicado: (2022)